FS

Farhanaz Sultana

Active Director Director DIN 09787422
DIN 09787422 First appointment Nov 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Farhanaz Sultana

Data last updated:

Farhanaz Sultana is a Director at Toyenbee Pharma Private Limited (since 2022). The company operates in Chemicals. Toyenbee Pharma Private Limited reported revenue of ₹34.1 Lakh (FY 2024).

DIN 09787422
Primary Designation Director
Industry Chemicals
First Appointment 11 Nov 2022
Oldest Company Age 3 yrs
Largest company Toyenbee Pharma Private Limited · ₹34.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Toyenbee Pharma Private Limited U24299AS2022PTC023834
Director11 Nov 20222022₹34.1 Lakh (FY 2024)Active

Board colleagues of Farhanaz Sultana

Directorship timeline

Open interactive timeline →
Toyenbee Pharma Private Limited
Premium access

Shareholding and investment profile for Farhanaz Sultana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Farhanaz Sultana

Farhanaz Sultana currently holds 1 directorship: Toyenbee Pharma Private Limited (Director, since 11 Nov 2022, revenue ₹34.1 Lakh (FY 2024)).

Farhanaz Sultana was first appointed on 11 Nov 2022 as Director at Toyenbee Pharma Private Limited.

The current boards of Farhanaz Sultana's companies include Mostakin Ansari (Toyenbee Pharma Private Limited), Shaikh Farid Ahmed (Toyenbee Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available